Sign in
4

Changes in Ownership

Tarsus Pharmaceuticals, Inc. Filed Acc 0002044770-26-000006

Director sold 2,954 shares at $62.08 ($183,384)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goodrich Katherine · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Sale : show line 1 in the form 10b5-1 −2,954 $62.08 $183,384 2,233 D
Open-market sales · 2,954 sh · avg $62.08 · $183,384
Loading xslF345X06/wk-form4_1781727435.xml…